At Baxter Healthcare, Ms Hofstetter conducted numerous market studies for new technologies and innovative therapies, combining drugs and devices. She was involved in the company’s acquisition efforts.
In addition, she was responsible for Interventional Cardiology marketing and European-wide new product launches.

At ESPE Dental AG, Ms Hofstetter managed global concept development, implementation and performance measurement for a major product line. Further she had a management role in defining the strategic direction of a business unit together with profit and loss responsibilities.

With HealthStrat, she has developed an extensive network in the clinical and business environment to complete assignments for healthcare companies and venture capital firms.

She is attending more than ten national and international medical meetings a year to keep pace with new technologies and therapeutic approaches.